Mitral regurgitation affects more than 2 million people in the USA. The main causes are
classified as degenerative (with valve prolapse) and ischaemic (ie, due to consequences of …

Ischemic mitral regurgitation (IMR) is a common complication of coronary artery disease and
is the focus of a rapidly increasing amount of research. Mechanistic studies have determined …

Background Ischemic mitral regurgitation is associated with increased mortality and
morbidity. For surgical patients with moderate regurgitation, the benefits of adding mitral …

Importance The outcomes of patients with left ventricular (LV) dysfunction and secondary
mitral regurgitation (SMR) are still controversial. Objective To clarify the role of SMR in the …

The Japanese Circulation Society (JCS) published the “Guidelines for elective percutaneous
coronary intervention [PCI] in patients with stable coronary disease” in 2000. In 2006 …

In addressing the current therapy for mitral regurgitation (MR), it is useful to distinguish
primary MR from secondary (functional) MR. In primary MR, abnormalities of one or more of …

Background—The optimal treatment for ischemic mitral regurgitation remains actively
debated. Our objective was to evaluate the relationship between ischemic mitral …

BACKGROUND: Mortality for patients with coronary artery disease and functional ischemic
mitral regurgitation (IMR) remains high regardless of the treatment strategy. Data regarding …

Aims To assess long‐term prognosis in patients with functional mitral regurgitation (FMR)
and left ventricular (LV) dysfunction, receiving current standard pharmacological therapy …

BACKGROUND: The aim of the study was to evaluate the clinical and echocardiographic
outcomes, at rest and under exercise testing, of patients with moderate ischemic mitral …